A Study to clinically evaluate Mustadi Seka, Yoganjana and Shirolepa in Praklinna Vartma(Seborrhoeic Blepharitis)

An open - randomized clinical study to evaluate the combined effect of Mustadi Seka, Yoganjana and Shirolepa in Praklinna Vartma (Seborrhoeic Blepharitis) - NIL

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/10/074646

Enrollment

Registered

2024-10-03

Start date

Unknown

Completion date

Unknown

Last updated

2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H010- Blepharitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients with classical sign and symptoms of Praklinn Vartma (Seborrhoeic Blepharitis) .Patient of age group 12 to 60 years of either sex will be taken in this study .

Exclusion criteria

Exclusion criteria: Patient having diseases like corneal ulcers ,dacryocystitis ,dry eye,lagophthalmos ,infective conjunctivitis etc. Patients suffering from specific eyelid disorders like ectropion ,entropion ,trichiasis ,tumours,carcinoma ,skin allergies Systemic Diseases like Diabetes Mellitus ,Hypertension .

Design outcomes

Primary

Measure	Time frame
To Study The Conceptual Resemblance Between Praklinna Vartma and Seborrhoeic BlepharitisTimepoint: To Study The Conceptual Resemblance Between Praklinna Vartma and Seborrhoeic Blepharitis	—

Secondary

Measure	Time frame
To evaluate combined effect of Mustadi Seka ,Yoganjana and Shirolepa in Praklinna VartmaTimepoint: 21 days	—

Countries

India

Contacts

Public ContactDr Shruti Vaishnava

Rishikul Campus UAU

chauhanpriyanka40@gmail.com7500402154

Outcome results